Tandem Diabetes Care Inc (TNDM) reported quarterly earnings results on Thursday, Jul-28-2016. The company said it had a profit of $-0.60 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.05. Analysts had a consensus of $-0.65. The company posted revenue of $23.00 million in the period, compared to analysts expectations of $23.08 million. The company’s revenue was up 46.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.65 EPS.
Tandem Diabetes Care Inc opened for trading at $7.7 and hit $7.96 on the upside on Thursday, eventually ending the session at $7.78, with a gain of 1.04% or 0.08 points. The heightened volatility saw the trading volume jump to 1,53,141 shares. Company has a market cap of $236 M.
In a different news, on May 2, 2016, John F Sheridan (EVP, CHIEF OPERATING OFFICER) sold 2,000 shares at $10.61 per share price. According to the SEC, on Aug 4, 2015, Howard E Jr Greene (director) sold 20,000 shares at $12.70 per share price.
Tandem Diabetes Care Inc. is a medical device company engaged in designing developing and commercializing products for people with insulin-dependent diabetes. The Company’s products include t:slim Insulin Delivery System (t:slim) and t:flex Insulin Delivery System (t:flex). The t:slim consists of the t:slim pump its 300-unit disposable insulin cartridge and an infusion set. The t:flex consists of the t:flex pump its 480-unit disposable insulin cartridge and an infusion set. The Company’s technology platform features Micro-Delivery Technology a miniaturized pumping mechanism which draws insulin from a flexible bag within the pump’s cartridge rather than relying on a syringe and plunger mechanism.